Only 10 states are currently contributing to 75 percent of active COVID-19 cases in India: Minister

Published On 2020-09-24 04:00 GMT   |   Update On 2020-09-24 04:00 GMT

New Delhi: Only 10 states are currently contributing to 75% of active cases in the country, which suggests that COVID is still limited in the spread, the Minister of Health and Family Welfare, Ashwini Kumar Choubey recently informed the parliament.The detailed breakdown of community transmission of COVID-19 across the country was in response to a query raised during a recent Lok Sabha...

Login or Register to read the full article

New Delhi: Only 10 states are currently contributing to 75% of active cases in the country, which suggests that COVID is still limited in the spread, the Minister of Health and Family Welfare, Ashwini Kumar Choubey recently informed the parliament.

The detailed breakdown of community transmission of COVID-19 across the country was in response to a query raised during a recent Lok Sabha session that sought the details of the first case of community transmission of COVID-19 observed and the total number of such cases in the relevant States/UTs at that time, State/UT-wise and action taken by the Government to stop community transmission.

Responding to the question, Choubey stated that the epidemic curve of any pandemic goes through an ascending, peaking, and descending phase. The current phase of the pandemic in India is on multiple trajectories across the urban and semi-urban areas of the country. India has reported large outbreaks in certain districts indicating the spread of infection in those districts.

"Only 10 States are currently contributing to 75% of active cases in the country, which suggests that COVID is still limited in spread (details at Annexure I). India has among the lowest cases and deaths per million population among similarly affected countries. This is further corroborated by the fact that the nationwide seroprevalence for COVID-19 conducted in May 2020 was found to be less than 1%," the Minister added.

Top 10 states/UTs with most active cases (as on 20th September 2020)

State/UT

Total number of active

cases

Percentage contribution to total active

cases in the country

Maharashtra

297866

29.47%

Karnataka

98583

9.75%

Andhra Pradesh

81763

8.09%

Uttar Pradesh

66874

6.62%

Tamil Nadu

46453

4.60%

Kerala

37535

3.71%

Chhattisgarh

37489

3.71%

Odisha

33202

3.28%

Delhi

32064

3.17%

Telangana

30573

3.02%

While elaborating on further queries regarding the details of the protocol recommended by the Government to prevent the further community transmission of COVID-19, and the date of identification of the first instance of an active case of COVID-19 which could not be traced to a known infected contact and with no travel history, the Minister said that the government of India has adopted a containment strategy for containing the spread of COVID-19 by suppressing/breaking the cycle of transmission in the country. The containment plans envisage a strategy of breaking the chain of transmission by (i) defining containment and buffer zones, (ii) applying strict perimeter control, (iii) intensive active house to house search for cases and contacts, (iv) isolation and testing of suspect cases and high-risk contacts, (v) quarantine of high-risk contacts, (vi) intensive risk communication to raise community awareness on simple preventive measures and need for prompt treatment-seeking and (vii) strengthening of passive Influenza-Like Illness (ILI)/ Severe Acute Respiratory Illness (SARI) surveillance in containment and buffer zones.

State/UT wise details of total COVID-19 cases and tests conducted (as reported on 20th September, 2020) read;

S. No.

Name of State / UT

Total Cases

Total samples

tested

1

Andaman & Nicobar Islands

3644

37595

2

Andhra Pradesh

617776

4760533

3

Arunachal Pradesh

7250

109932

4

Assam

155453

2246763

5

Bihar

166788

5095174

6

Chandigarh

9796

65031

7

Chhattisgarh

84234

797597

8

Daman & Diu and Dadra & Nagar Haveli

2887

62296

9

Delhi

242899

2571746

10

Goa

28022

254779

11

Gujarat

121768

3393279

12

Haryana

108952

1665306

13

Himachal Pradesh

11908

284101

14

Jammu & Kashmir

62533

938317

15

Jharkhand

69860

1591990

16

Karnataka

511346

4265333

17

Kerala

131005

1301622

18

Ladakh

3708

40095

19

Lakshdweep

0

3210

20

Madhya Pradesh

103065

1886861

21

Maharashtra

1188015

5641371

22

Manipur

8724

185203

23

Meghalaya

4557

91495

24

Mizoram

1578

59762

25

Nagaland

5392

38267

26

Odisha

175550

2791317

27

Puducherry

22456

106222

28

Punjab

95529

1558454

29

Rajasthan

113124

2548045

30

Sikkim

2423

35774

31

Tamil Nadu

536477

6240959

32

Telangana

171306

1639039

33

Tripura

22032

324739

34

Uttar Pradesh

348517

8249091

35

Uttarakhand

40085

563829

36

West Bengal

221960

2717710

Dealing with the question, whether the government has any plan to reduce the charge/fee of RT-PCR or TrueNat or CBNAAT or RAT test in the country, Choubey stated that in all public health institutions under the jurisdiction of the Ministry of Health & Family Welfare COVID-19 tests such as RT-PCR, Truenat, CBNAAT, and Rapid Antigen test are done free of cost. ICMR has also provided COVID-19 testing reagents to all the States and UTs free of cost. As health is a State subject, the Ministry of Health & Family Welfare has also written to all States/UTs to negotiate with private laboratories and fix up mutually agreeable prices for samples being sent by the government and also for private individuals desirous of testing by these laboratories.

To access the official statement click on the link below-

https://medicaldialogues.in/pdf_upload/pdf_upload-134989.pdf

Also Read: Social distancing crucial to prevent community transmission of Coronavirus: IMA

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News